[
  {
    "ts": "2025-01-30T23:45:00+00:00",
    "headline": "Top Analyst Reports for Alibaba, Airbnb & Royal Caribbean Cruises",
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), Airbnb, Inc. (ABNB) and Royal Caribbean Cruises Ltd. (RCL), as well a micro-cap stock DallasNews Corporation (DALN).",
    "url": "https://finance.yahoo.com/news/top-analyst-reports-alibaba-airbnb-234500157.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "5d9a7bfa-38d0-3432-98f9-59dd83e7d84a",
      "content": {
        "id": "5d9a7bfa-38d0-3432-98f9-59dd83e7d84a",
        "contentType": "STORY",
        "title": "Top Analyst Reports for Alibaba, Airbnb & Royal Caribbean Cruises",
        "description": "",
        "summary": "Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), Airbnb, Inc. (ABNB) and Royal Caribbean Cruises Ltd. (RCL), as well a micro-cap stock DallasNews Corporation (DALN).",
        "pubDate": "2025-01-30T23:45:00Z",
        "displayTime": "2025-01-30T23:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/27128fdf68f183170008538bbd9e5400",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rmXxohCxV1lmwN6FKUlUHw--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/27128fdf68f183170008538bbd9e5400.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fgFUflRwls_qLqb4YzH5Hw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/27128fdf68f183170008538bbd9e5400.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-analyst-reports-alibaba-airbnb-234500157.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-analyst-reports-alibaba-airbnb-234500157.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABNB"
            },
            {
              "symbol": "BABA"
            },
            {
              "symbol": "RCL"
            },
            {
              "symbol": "EW"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-01-30T19:21:34+00:00",
    "headline": "Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion",
    "summary": "Edwards Lifesciences Corporation (NYSE:EW) shares are trading higher on Thursday. Stifel analyst Rick Wise upgraded Edwards from Hold to Buy, raising the price forecast to $90 from $75. Wise suggests that recent conversations with six Transcatheter aortic valve replacement (TAVR) physicians and a follow-up survey of thirty doctors support the view that TAVR growth could re-accelerate in 2025. These physicians are already seeing an increase in post-EARLY TAVR referrals, the analyst notes. Additio",
    "url": "https://finance.yahoo.com/news/edwards-lifesciences-poised-solid-growth-192134571.html",
    "source": "Benzinga",
    "provider": "yfinance",
    "raw": {
      "id": "65f4ef72-2648-3019-8db5-3a0c577b6af2",
      "content": {
        "id": "65f4ef72-2648-3019-8db5-3a0c577b6af2",
        "contentType": "STORY",
        "title": "Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion",
        "description": "",
        "summary": "Edwards Lifesciences Corporation (NYSE:EW) shares are trading higher on Thursday. Stifel analyst Rick Wise upgraded Edwards from Hold to Buy, raising the price forecast to $90 from $75. Wise suggests that recent conversations with six Transcatheter aortic valve replacement (TAVR) physicians and a follow-up survey of thirty doctors support the view that TAVR growth could re-accelerate in 2025. These physicians are already seeing an increase in post-EARLY TAVR referrals, the analyst notes. Additio",
        "pubDate": "2025-01-30T19:21:34Z",
        "displayTime": "2025-01-30T19:21:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Benzinga",
          "url": "http://www.benzinga.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-poised-solid-growth-192134571.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-poised-solid-growth-192134571.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-01-30T15:21:00+00:00",
    "headline": "Edwards Lifesciences Q4 Earnings Set to Benefit From TAVR Growth",
    "summary": "Favorable hospitalization trend, strong adoption of transcatheter heart valves and improved procedural volume are expected to have aided EW in the fourth quarter.",
    "url": "https://finance.yahoo.com/news/edwards-lifesciences-q4-earnings-set-152100919.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e69d3d3f-1997-36f8-a726-5b3864dbd438",
      "content": {
        "id": "e69d3d3f-1997-36f8-a726-5b3864dbd438",
        "contentType": "STORY",
        "title": "Edwards Lifesciences Q4 Earnings Set to Benefit From TAVR Growth",
        "description": "",
        "summary": "Favorable hospitalization trend, strong adoption of transcatheter heart valves and improved procedural volume are expected to have aided EW in the fourth quarter.",
        "pubDate": "2025-01-30T15:21:00Z",
        "displayTime": "2025-01-30T15:21:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/51f0c2cd09522c9a15cba48260e4facf",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dnO5nPYh1EXzUXNDzu6_sQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/51f0c2cd09522c9a15cba48260e4facf.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SnXfC6dyaIxkMGLLjBShMA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/51f0c2cd09522c9a15cba48260e4facf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-q4-earnings-set-152100919.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-q4-earnings-set-152100919.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]